News

Researchers create a microfluidic “lab on a chip” that uses light to monitor biofilm formation and biofilm response to drugs, detects growth and thickening of biofilms by monitoring translucency.

Collaboration will support faster and more flexible facility construction and shortened time to market.

Almac to manufacture the production of the gram positive antibacterial compound MGB-BP3.

French defence procurement agency invests EUR 900,000 towards a Pherecydes Pharma managed EUR 1.2-million project.

The United States Patent and Trademark Office (USPTO) has issued out US Patent, with fundamental claims directed to methods of gene silencing in many organisms.

Medicinal Genomics, as a wholly owned subsidiary of Courtagen, will apply next-generation sequencing technologies to better understand and elucidate the medical properties of Cannabis.

The findings, reported in the journal Nature Medicine, have important implications for patients and may help to monitor their condition and prevent the development of cancer.

The Celling Biosciences company, that designs, develops and markets innovative technologies in the field of regenerative medicine, is pleased to announce the addition of Dr. Matthew Murphy to its team of PhDs.

The DPN 5000 System will be used for supramolecular structure fabrication, molecular recognition and self-assembling process applications.

Stellar Biotechnologies, Inc. is pleased to announce that it has retained TheBiotechPanel, Inc. to provide the Company with investor relations services, for an initial period of six months.